Select a community
All Communities
Home > Community Treatment Reports > Aplenzin (bupropion) Treatment Report
What is Aplenzin?

Aplenzin is a brand name for an extended release and once daily dosage formulation of the antidepressant, bupropion, a norepinephrine and dopamine reuptake inhibitor (NDRI) used for the treatment of depression. It is also approved for the prevention of seasonal affective disorder.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Major Depressive Disorder 3 1
Bipolar Disorder 2 2

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
1 33%
None
2 67%

Most commonly reported side effects

dry mouth
1 33%
  • Mild
  • Moderate
  • Severe

Dosages

  348 mg daily hydrobromide 522 mg/24 hours daily
  1 Number of Patients: 1 3 Number of Patients: 3  

Stop Reasons

Why Patients Stopped Taking Aplenzin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Expense
1 100% Expense: 100%

See all 1 patient who’ve stopped taking Aplenzin

Duration See details about how long patients take this treatment ▼

Currently Taking Aplenzin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
2
0
1
1
0
0

Stopped Taking Aplenzin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
1 33%
Usually
1 33%
Sometimes
0 0%
Never
1 33%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
3 100%

Cost

Paid out of pocket

$200+
1 33%
$100-199
1 33%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.